Angiogenesis in cutaneous lymphoproliferative disorders. Microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas

American Journal of Dermatopathology

Volumn 22, Issue 2, 2000, Pages 140-143

  Schaerer, Leo ^a   Schmid, Monika Hess ^a   Mueller, Beatrix ^a   Dummer, Reinhard G ^a   Burg, Gunter ^a   Kempf, Werner ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Angiogenesis; B cell pseudolymphomas; Cutaneous B cell lymphoma; Immunohistochemistry; Microvessel density

Indexed keywords

ANGIOGENESIS; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; PSEUDOLYMPHOMA;

BLOOD VESSELS; DIAGNOSIS, DIFFERENTIAL; ENDOTHELIUM; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; PSEUDOLYMPHOMA; SKIN NEOPLASMS;

EID: 0034106353     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-200004000-00009     Document Type: Article

References (15)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
2. Weidner N, Semple JP, Welch WR, Folkam J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
3. Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0mm thick) skin melanoma: a quantitative histologic study. Am J Pathol 1988;133:419-23.
4. Vacca A, Ribatti D, Roncali L, Dammacco F. Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies. Leuk Lymphoma 1995;20:27-38.
5. Smolle J, Torne R, Soyer HP. Immunohistochemical classification of cutaneous lymphomas: delineation of distinct patterns. J Cutan Pathol 1990;17:149-59.
6. Burg G, Braun-Falco O, Hoffman-Fezer G, Schmoeckel C. Differentiation between pseudolymphomas and malignant B-cell lymphomas of the skin. In: Goos M. Christophers E, eds. Lymphoproliverative diseases of the skin. Berlin: Springer Verlag, 1982.
7. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood 1997;90:354-71.
8. Ribatti D, Vacca A, Nico B, Fanelli M, Ronacalli L, Dammacco F. Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study. Eur J Haematol 1996;56:45-53.
9. Freeman MR, Schneck FX, Gagnon ML, et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res 1995;55:4140-5.
10. Gruber BL, Marchese MJ, Kew R. Angiogenic factors stimulate mast-cell migration. Blood 1995;86:2488-93.
11. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and neoangiogenesis. Am J Pathol 1995;146: 1029-39.
12. Foss HD, Araujo I, Demel G, Klotzbach H, Hummel M, Stein H. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. J Pathol 1997;183:44-50.
13. Pesenti E, Sola F, Mongelli N, Grandi M, Spreafico F. Suramin prevents neovascularisation and tumor growth through blocking of basic fibroblast growth factor activity. Br J Cancer 1992;66(2): 367-72.
14. Yamamoto T, Sudo K, Fujita T. Significant inhibition of endothelial cell growth in tumor vasculature by an angiogenesis inhibitor, TNP-470(AGM-1470). Anticancer Res 1994;14(1A):1-3.
15. Hoffer FA, Taylor GA, Spevak M, Ingber D, Hanahan D. Metabolism of tumor regression from angiogenesis inhibition: 31P magnetic resonance spectroscopy. Magn Reson Med 1989;11(2): 202-8.